2005

Bataille F , Rogler G, Poser I, Modes K, Mühlbauer M, Dietmaier W, Rümmele P, Wallner S, Hellerbrand C and Bosserhoff AK: Characterization of expression of methylthioadenosin phosphorylase (MTAP) in normal human colonic epithelial cells and colon carcinoma. Lab Invest 85: 124-136 (2005)

von Walter M, Rueger M, Ragoß C, Steffens GCM, Hollander D, Paar O, Maier HR, Jahnen-Dechent W, Bosserhoff AK, and Erli HJ: In vitro behaviour of a porous TiO2/perlite composite and its surface modification with fibronectin. Biomaterials 26:2813-2826 (2005)

Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM, Müller-Ladner U, Schölmerich J,  Hellerbrand C: The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. JID 124: 92-98 (2005)

Jachimczak P, Kempt P, Tschertner I, Jachnik B, Thurner B, Schlingensiepen KH, Bosserhoff AK, Bogdahn U, Apfel R: Immunosuppressive effects of Melanoma - inhibiting Activity (MIA)  - a possible role in tumor - host interactions. Int. J. Cancer 113:88-92 (2005)

Rothhammer T, Poser I, Soncin F, Bataille F, Moser M, Bosserhoff AK: Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration. Cancer Res. 65: 92-98 (2005)

Tatzel J, Poser I, Schroeder J, Bosserhoff AK: Molecular changes in MIA deficient melanoma cells: re-differentiation? Inhibition of Melanoma Inhibitory Activity (MIA) expression in melanoma cells leads to molecular and phenotypic changes. Pigment Cell Research 18: 92 – 101 (2005)

Hellerbrand C, Bataille F, Schlegel J, Hartmann A, Mühlbauer M, Schölmerich J, Buettner R, Hofstädter F, Bosserhoff AK: In situ expression patterns of melanoma inhibitory activity 2 (MIA2) in healthy and diseased livers. Liver Int. 25: 357 – 366 (2005)

Schimanski CC, Schmitz G, Kashyap A, Bosserhoff AK, Bataille F, Lehr HA, Berger MR, Galle PR, Strand S and Strand D: Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 24: 3100 – 3109 (2005)

Poser I, Rothhammer T, Dooley S, Weiskirchen R, Bosserhoff AK: Characterization of Sno expression in malignant melanoma. International J Oncol. 26: 1411 – 1417 (2005)

Bataille F, Troppmann S, Klebl F, Rogler G, Stoelcker B, Hofstädter F, Bosserhoff AK, Rümmele P: Multiparameter - Immunofluorescence on paraffin-embedded tissue sections. Applied Immunohistochemistry & Molecular Morphology (in press)

Roeb E, Bosserhoff AK, Hamacher S, Jansen B, Matern S: Enhanced migration of TIMP-1 overexpressing liver cells is attributed to MMP activity and can be abrogated by TIMP-1 inhibition. World J. Gastro 11: 1096 – 1104 (2005)

Bauer R, Hein R, Bosserhoff AK: A secreted form of P-cadherin is expressed in malignant melanoma. ECR 305:418-426 (2005)

Wild PJ, Krieg RC, Seidl J, Stöhr R, Dietmaier W, Reher K, Louhelainen J, Rosenthal A, Hartmann A, Pilarsky C, Bosserhoff A, Knüchel R: RNA-expression profiling of normal and tumor cells in vitro following photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) induced protoporphyrin IX (PPIX). Molecular Cancer Therapeutics 4: 516 – 528 (2005)

Fitori JE, Kleeff J, Giese NA, Guweidhi A, Bosserhoff AK, Buechler MW, Friess H: Melanoma Inhibitory Activity (MIA) increases invasiveness of pancreatic cancer. Cancer Cell Internat. 5: 3 (2005)

Reiniger IW, Schaller UC, Haritoglou C, Hein R, Bosserhoff AK, Kampik A, Mueller AJ: Melanoma Inhibitory Activity (MIA): a specific and sensitive serological tumor marker in metastatic uveal melanoma. Graefes Arch Clin Exp Ophthalmol (accepted)

Kuphal S, Palm HG, Poser I and Bosserhoff AK: Snail-regulated genes in malignant melanoma. Melanoma Res. 15:305-313 (2005)

Hau P, Kunz-Schughart L, Ruemmele P, Arslan F, Doerfelt A, Koch H, Lohmeier A, Hirschmann B, Mueller A, Bogdahn U, Bosserhoff AK: Tenascin-C is induced by Transforming Growth Factor-ß1 in High-Grade Gliomas but does not Correlate with Time to Tumor Progression. J Neuro-Oncology (accepted)

Kuphal S, Bosserhoff AK: Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma. Oncogene (accepted)

Kuphal S, Wallner S, Schimanski CC, Bataille F, Hofer P, Strand S, Strand D, Bosserhoff AK: Expression of Hugl-1 is strongly reduced in malignant melanoma. Oncogene (accepted)

Arndt S, Poser I, Schubert T, Moser M, Bosserhoff AK: Cloning and functional characterization of a new Ski homolog protein, Fussel-18, which is specifically expressed in neuronal tissues. Lab Invest 85:1330-1341 (2005)